Author:
Spugnini Enrico P,Biroccio Annamaria,De Mori Roberta,Scarsella Marco,D'Angelo Carmen,Baldi Alfonso,Leonetti Carlo
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference60 articles.
1. Eckstein F: Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?. Antisense Nucleic Acid Drug Dev. 2000, 10: 117-121. 10.1089/oli.1.2000.10.117.
2. Gleave ME, Monia BP: Antisense therapy for cancer. Nat Rev Cancer. 2005, 5: 468-479. 10.1038/nrc1631.
3. Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro GC, Zupi G: Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice. J Natl Cancer Inst. 1996, 88: 419-429. 10.1093/jnci/88.7.419.
4. Leonetti C, Biroccio A, Candiloro A, Citro G, Fornari C, Mottolese M, Del Bufalo D, Zupi G: Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin. Clin Cancer Res. 1999, 5: 2588-2595.
5. Zupi G, Scarsella M, Semple SC, Mottolese M, Natali PG, Leonetti C: Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of administration sequence. Clinical Cancer Res. 2005, 11: 1990-1995. 10.1158/1078-0432.CCR-04-1284.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献